DNA methylation as a universal biomarker
- 1 May 2010
- journal article
- review article
- Published by Informa UK Limited in Expert Review of Molecular Diagnostics
- Vol. 10 (4), 481-488
- https://doi.org/10.1586/erm.10.17
Abstract
Cell-free circulating DNA carries not only tumor-specific changes in its sequence but also distinctive epigenetic marks, namely DNA methylation, in certain GC-rich fragments. These fragments are usually located within the promoters and first exons of many genes, comprising CpG islands. Analysis of DNA methylation using cell-free circulating DNA can facilitate development of very accurate biomarkers for detection, diagnosis, prediction of response to therapy and prognosis of outcomes. Recent data suggest that benign and inflammatory diseases have very specific methylation patterns within cell-free circulating DNA, which are different from the pattern of a malignant tumor of the same organ. In addition, specific methylation patterns have been detected for cancers of different organs, so a differential diagnosis of site-specific cancer appears feasible. Currently, cancer-related applications dominate the field, although methylation-based biomarkers may also be possible for other diseases, including neurodegenerative and psychiatric disorders.Keywords
This publication has 84 references indexed in Scilit:
- Methylated DNA Immunoprecipitation and Microarray-Based Analysis: Detection of DNA Methylation in Breast Cancer Cell LinesMethods in Molecular Biology, 2009
- Imprinting Disorders and Assisted Reproductive TechnologySeminars in Reproductive Medicine, 2009
- Instability and chromatin structure of expanded trinucleotide repeatsTrends in Genetics, 2009
- Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapyBritish Journal of Cancer, 2009
- CpG islands – ‘A rough guide’FEBS Letters, 2009
- Epigenetics, oxidative stress, and Alzheimer diseaseFree Radical Biology & Medicine, 2009
- Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatmentSeminars in Cancer Biology, 2009
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecologic Oncology, 2009
- Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCRNucleic Acids Research, 2007
- Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylationBritish Journal of Cancer, 2006